NKF 2011 Spring Meeting

Vitamin D Replacement May Lower CV Event Risk

LAS VEGAS—Treatment of 25-hydroxyvitamin D (25(OH)D) deficiency with ergocalciferol in patients with moderate chronic kidney disease (CKD) is associated with a significant reduction in the risk of cardiovascular (CV) events, new data presented at the National Kidney Foundation’s Spring Clinical Meetings suggest.

Switch From Darbepoetin to Epoetin May Be Beneficial

LAS VEGAS—Switching anemic pre-dialysis chronic kidney disease (CKD) from darbepoetin to epoetin is associated with longer dosing intervals and lower drug costs, and hemoglobin levels are maintained in the recommended target range, according to a study presented at the National Kidney Foundation’s Spring Clinical Meetings.

Study: Women Are At Higher Risk of RCIN

LAS VEGAS—Women with an estimated glomerular filtration rate (eGFR) of 60 mL/min/1.73 m2 or higher are at higher risk than men for experiencing radiocontrast-induced nephropathy (RCIN) following coronary angiography, investigators reported at the National Kidney Foundation’s Spring Clinical Meetings.

SLEDD Offers No Advantage Over IHD

LAS VEGAS—Sustained low-efficiency daily dialysis (SLEDD) for intensive care unit (ICU) patients does not offer a survival advantage over intermittent hemodialysis (IHD), according to data reported at the National Kidney Foundation’s Spring Clinical Meetings.

Next post in NKF 2011 Secondary Hyperparathyroidism